Diethylstilbestrol (DES, 1 x 10–6 M) inhibited norepinephrine (NE)-induced contractions of isolated rat aortic strips only at low doses of NE in contrast to estradiol-17β (1 x 10–5M) which depressed only the response to high doses. The degree of inhibition increased over a period of 90 min exposure to the estrogens. Microsomes accumulated more 14C-DES per milligram protein than any other subcellular fraction of rat aorta. This accumulation process appears to be gradual requiring many minutes which may explain the gradual increase in intensity of the inhibitory effect with increased time of exposure to DES. The contrasting inhibitory effects of DES and estradiol in rat aorta may be due to non-homogeneous solution of these drugs in smooth muscle plasma membranes. DES, but not estradiol, caused contraction of isolated aortic strips prior to the onset of inhibition. This contraction showed fade and tachyphylaxis, was antagonized by α-adrenergic blockers, and was enhanced by prior treatment of the strips with NE. Thus, DES but not estradiol is capable of mobilizing NE from storage sites in rat aorta.

Keywords:
Estrogens, Rat aorta, Subcellular fractions
This content is only available via PDF.
© 1981 S. Karger AG, Basel
1981
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.